Purpose Although fear of recurrence (FCR) is common among cancer survivors, it remains unclear what factors predict initial levels (e.g., prior to surgery) or changes in FCR in the post-treatment period. Among women treated for breast cancer, this study evaluated the effects of demographic, clinical, symptom, and psychosocial adjustment characteristics on the initial (preoperative) levels of FCR and trajectories of FCR over 6 months following surgery. Methods Prior to and for 6 months following breast cancer surgery, 396 women were assessed for demographic and clinical (disease and treatment) characteristics, symptoms, psychological adjustment characteristics, and quality of life (QOL). FCR was assessed using a four-item subscale from the QOL instrument. Hierarchical linear modeling was used to examine changes in FCR scores and to identify predictors of inter-individual differences in preoperative FCR levels and trajectories over 6 months.
Introduction
Fear of cancer recurrence (FCR) is one of the most pervasive concerns and unmet needs of cancer survivors [1] [2] [3] [4] [5] . FCR is associated with decrements in mental, physical, and social aspects of quality of life (QOL) and can persist long after completion of active treatment [2, [6] [7] [8] [9] [10] . For example, a recent study of long-term breast cancer survivors found that even after an average of 8 years from diagnosis, 82 % of survivors had at least low levels of FCR, while 17 % had either moderate or high levels of FCR [10] . Across a number of cross-sectional studies, FCR was positively correlated with anxiety [11] [12] [13] [14] [15] [16] [17] [18] [19] , avoidance [7, 11, 12, 14, 15] , depressive symptoms [2, 11, 12, [14] [15] [16] [17] 20] , denial [16] , cognitive intrusions [2, 11, 12, 14, 15] , maladaptive metacognitions (i.e., negative thoughts about one's own thoughts) [21] , and higher threat appraisal [22] . However, findings are inconsistent regarding the relationships between FCR and disease stage or treatment [1, 5, 7, [23] [24] [25] .
A number of longitudinal studies evaluated FCR among cancer survivors in order to identify its prevalence, persistence, and risk factors (see [1, 26] for systematic reviews). A recent systematic review found that FCR tended to remain stable over time and that higher baseline levels of FCR predicted higher levels of FCR over time [1] . This is corroborated by a large longitudinal study of 962 patients who underwent cancer surgery [5] . In this study, the authors used an empirically established cut-point for clinically significant levels of FCR and found prevalence rates of FCR from 44 to 56 %, with the highest scores reported at baseline. However, among existing longitudinal studies, predictors of FCR varied considerably across studies [5] . Moreover, because linear or logistic regression analyses were typically performed, little is known about demographic and clinical characteristics that predict inter-individual differences in initial levels of and changes in FCR over time.
"Inter-individual differences" or "inter-individual variability" refers to differences between people in multilevel models. Such differences can be due to categorical differences (i.e., differences between groups) or associations with measured characteristics of people (e.g., age, some type of score or measure) [27] . Furthermore, differences or associations between characteristics of people can be found at the baseline measure, and they can affect the way people change over time (the change trajectory or the "growth" trajectory).
Using hierarchical linear modeling (HLM), a type of longitudinal data analysis, our group has examined interindividual variability in commonly experienced symptoms among cancer patients with a range of diagnoses [28] [29] [30] [31] [32] . HLM affords the opportunity to examine inter-individual differences in the trajectories of a specific outcome measure of interest. Its usefulness in the context of FCR is to identify what demographic and clinical characteristics predict initial levels of FCR, as well as the trajectories of FCR over time. This is important because it may help identify individuals at risk of higher levels of FCR during and after cancer treatment. Only one study was found that used a type of HLM to evaluate FCR over time [33] . In this prospective study, Actor-Partner Independence Model (APIM) was used to examine predictors of FCR in cancer survivors and their family caregivers. This study identified higher level of family stressors, less positive meaning of the illness, and younger age as predictors of fear of recurrence in both patients and family caregivers [33] .
To our knowledge, no studies have used HLM to evaluate predictors of inter-individual differences in FCR in a diagnostically homogeneous sample of breast cancer patients prior to and following breast cancer surgery. Such an analysis would enhance our understanding of what factors contribute to elevated FCR prior to surgery and to changes in the levels of FCR in the post-treatment period. Therefore, the purposes of this exploratory study were to identify the trajectories of FCR among women who were assessed preoperatively and monthly for 6 months following breast cancer surgery and to evaluate whether specific demographic, clinical, symptom, and psychosocial adjustment characteristics predicted the initial (preoperative) levels of FCR and characteristics of the trajectories of FCR over the 6 months following surgery.
Methods

Patients and settings
Patients and settings This study is a secondary analysis that utilized data from a longitudinal, descriptive study that evaluated neuropathic pain and lymphedema in a sample of women who underwent breast cancer surgery. The methods for this study have been described in detail elsewhere [34] [35] [36] [37] . In brief, patients were recruited from Breast Care Centers located in a Comprehensive Cancer Center, two public hospitals, and four community practices. Women were eligible if they were ≥18 years of age; were scheduled to undergo breast cancer surgery on one breast; were able to read, write, and understand English; and provided written informed consent. Patients were excluded if they were having bilateral breast cancer surgery and/or had distant metastasis at the time of diagnosis. A total of 516 patients were approached and 410 enrolled in the study (response rate, 79.5 %). The major reasons for refusal were too busy, overwhelmed with the cancer diagnosis, or insufficient time available to complete the baseline assessment prior to surgery. Patients who declined participation did not differ significantly from those who enrolled in terms of key demographic or clinical characteristics.
Instruments At enrollment, demographic information was obtained. At each subsequent assessment, patients provided information on current treatments for breast cancer. Medical records were reviewed to obtain information on stage of disease, surgical procedure, neoadjuvant and adjuvant treatments, and reconstructive surgery.
The Karnofsky Performance Status (KPS) scale is widely used to evaluate functional status in patients with cancer and has well-established validity and reliability [38] . Patients rated their functional status using the KPS scale that ranged from 30 ("I feel severely disabled and need to be hospitalized") to 100 ("I feel normal; I have no complaints or symptoms").
The Self-Administered Comorbidity Questionnaire (SCQ), which was developed to assess comorbidity in clinical and health service research settings [39] , consists of 13 common medical conditions, rated for presence, treatment status, and functional limitations (range of possible scores, 0 to 39). The SCQ has well-established validity and reliability and has been used in studies of patients with a variety of chronic conditions [39, 40] .
The Center for Epidemiologic Studies-Depression (CES-D) scale consists of 20 items representing the major symptoms in the clinical syndrome of depression. Scores can range from 0 to 60, with scores of ≥16 indicating the need for clinical evaluation for major depression. The CES-D has wellestablished concurrent and construct validity [41, 42] . In the current study, the Cronbach's alpha was 0.90.
The Spielberger State-Trait Anxiety Inventories (STAI-T and STAI-S) consist of 20 items, each rated from 1 to 4. Total scores for each scale can range from 20 to 80, with higher scores indicating greater anxiety. The STAI-T measures a person's predisposition to anxiety and estimates how a person generally feels. The STAI-S measures an individual's transitory emotional response, with items assessing worry, nervousness, tension, and apprehension related to how a person feels "right now." Scores ≥31.8 and ≥32.2 suggest higher levels of trait and state anxiety, respectively [43, 44] . Both inventories have well-established criterion and construct validity and internal consistency [45] . In the current study, the Cronbach's alphas for the STAI-T and STAI-S were 0.88 and 0.95, respectively.
Patients were asked to indicate if they had pain in the breast. If they reported in the affirmative, they were asked to rate the intensity of their pain (i.e., pain now, average, and worst pain) using a Numeric Rating scale (NRS) that ranged from 0 (no pain) to 10 (worst imaginable pain). Numeric Rating scales are valid and reliable measures of pain intensity [46] .
The Quality of Life-Patient Version (QOL-PV) is a 41-item instrument that measures four dimensions of QOL in cancer patients (i.e., physical well-being, psychological well-being, spiritual well-being, social well-being), as well as a total QOL score. Each item is rated on a 0 to 10 NRS with higher scores indicating a better QOL. The QOL-PV has established validity and reliability [47, 48] . In the current study, the Cronbach's alpha for the QOL-PV total score was 0.86 and for the physical, psychological, social, and spiritual well-being subscales the coefficients were 0.70, 0.79, 0.75, and 0.61, respectively. For this analysis, the following individual items from the QOL-PV were selected as potential predictors based on prior literature and conceptual relationships to FCR [1, 8-10, 21, 49] : overall physical health, overall quality of life, happiness, feeling in control of things in life, life satisfaction, feeling useful, having sufficient support from others, importance of religious participation, importance of other spiritual activities, change in spiritual life since diagnosis, positive changes due to illness, having a purpose/mission for life, hopefulness, difficulty coping as a result of disease and treatment, distress related to initial diagnosis, distress of illness to family, interference with personal relationships, and isolation caused by illness or treatment.
Fear of cancer recurrence subscale Four items from the QOL-PV were selected to construct the FCR outcome measure. These items asked women to rate their fear of (1) future diagnostic tests, (2) a second cancer, (3) recurrence, and (4) metastasis, on a scale of 0 ("no fear") to 10 ("extreme fear"). The Cronbach's alpha for this four-item subscale was 0.94.
Study procedures
The Committee on Human Research at the University of California, San Francisco and at each study site approved the study. During the patient's preoperative visit, a staff member explained the study to the patient. For those women willing to participate, the staff member introduced the patient to the research nurse, who met with the women, determined eligibility, and obtained written informed consent prior to surgery. After providing consent, the patient completed the enrollment questionnaires (Assessment 0). Patients were contacted 2 weeks after surgery to schedule the first post-surgical appointment. The research nurse met with the patients in their home, the Clinical Research Center, or the clinic at 1, 2, 3, 4, 5, and 6 months after surgery. During each study visit, the women completed the study instruments.
Data analysis
Descriptive statistics and frequency distributions were generated on the sample characteristics. Baseline symptom severity was scored using SPSS version 22 (SPSS Inc, Chicago, Illinois). For each of the seven assessments, a mean FCR score was calculated as the outcome variable in the HLM analyses.
HLM, based on full maximum likelihood estimation, was done using the software developed by Raudenbush and colleagues [50] . Change in FCR scores was analyzed at two levels, as follows: within persons (level 1) and between persons (level 2). At level 1, FCR scores were a function of person-specific change parameters plus error. Three level 1 models were compared to determine whether the patients' FCR scores did not change over time (i.e., no time effect), changed at a constant rate (i.e., linear time effect), or changed at a rate that accelerated or decelerated over time (i.e., quadratic effect). At this point, the model was constrained to be unconditional (i.e., no predictors) and likelihood ratio tests were used to determine the best model. These analyses identified the change parameters that best described individual changes in FCR over time.
At level 2, FCR scores were modeled as the individual change parameters (i.e., intercept, slope) as a function of the proposed predictors listed in Table 1 . To improve estimation and efficiency, an exploratory level 2 analysis was completed in which each potential predictor was assessed to determine whether it was associated with FCR scores. Only predictors with t values ≥2.0, indicating a significant association, were selected for subsequent model testing. All significant predictors from the exploratory analyses were entered into the model to predict each individual change parameter. Only predictors that maintained a statistically significant contribution in conjunction with other variables were retained in the final model. Missing data on outcome measures was accommodated with full information maximum likelihood estimation [51] .
A p value of <0.05 indicated statistical significance. Combining level 1 with level 2 resulted in a mixed model with fixed and random effects [50] .
Results
Patient characteristics
The demographic, disease, symptom, and psychological adjustment characteristics of the 396 patients are presented in Table 2 . Patients were approximately 55 years of age, primarily white (65 %), well-educated, and had a high functional status score.
Individual and mean change in the outcome measures
The first HLM analysis examined how FCR scores changed over the course of 6 months. Two models were estimated in which the function of time was linear and quadratic. The final estimate of fixed effects revealed that a quadratic model fit the data best (see Table 3 ; Fig. 1a ). It should be noted that the mean scores for the groups depicted in Fig. 2a-h are estimated or predicted means based on the HLM analyses.
The estimates of the quadratic change model are presented in Table 3 (unconditional model). Because the model has no covariates (i.e., unconditional), the intercept represents the estimated mean FCR score (i.e., 5.67 on a 0 to 10 scale) prior to surgery. The estimated linear rate of change in FCR scores was −0.44 (p<0.001), and the estimated quadratic rate of change was 0.04 (p<0.001). As illustrated in Fig. 1a , FCR scores declined significantly across the 6 months of the study, but appeared to plateau at approximately 4 months.
Although the results indicate a sample-wide decline in FCR scores, they do not imply that all patients exhibited the same trajectories. The variance in individual change parameters estimated by the models (see "Variance components," Table 3) indicates substantial inter-individual differences in the intercept and trajectories of FCR scores. Therefore, examination of inter-individual differences in the individual change parameters was warranted. As shown in Fig. 1b , a spaghetti plot of individual trajectories from a random subset of patients visually demonstrates this variability in FCR scores. The second stage of the HLM analysis tested the hypothesis that the trajectories of FCR scores varied based on specific person, disease, treatment, symptom, and/or psychological adjustment characteristics that were found to influence FCR [1, 8, 25] . As shown in the final model in Table 3 , six characteristics predicted inter-individual differences in the intercept for FCR scores: living alone, changes in spiritual life since the cancer diagnosis, state anxiety prior to surgery (i.e., at enrollment), difficulty coping as a result of disease/treatment, distress related to the initial cancer diagnosis, and the distress (of illness) to family. Overall physical health and FCR scores prior to surgery were the only characteristics that significantly predicted linear and quadratic slope parameters.
To illustrate the effects of each of these characteristics on the intercepts and trajectories of FCR scores, Fig. 2 displays the adjusted change curves for FCR scores that were estimated based on differences in the significant predictors reported above. For the continuous variables, higher versus lower differences were calculated based on 1 standard deviation above/below the mean score.
In brief, patients who did not live alone, who experienced greater changes in spiritual life, had higher state anxiety at enrollment, had more difficulty coping, experienced more distress due to the diagnosis, and whose diagnosis caused more distress to family members reported higher FCR scores at enrollment. Patients who reported better overall physical health and higher FCR scores at enrollment demonstrated a steeper decrease in FCR scores, which leveled off approximately 4 months after breast cancer surgery, and appeared to plateau at approximately 6 months after surgery.
Discussion
This study is the only one, to our knowledge, that used HLM to evaluate predictors of change in FCR over time in women undergoing surgery for breast cancer. While previous literature demonstrated overall high levels, associated distress, and persistence of FCR [1] , the present study highlights the substantial amount of heterogeneity in the experience of FCR prior to surgery and over time in women with breast cancer. Corroborating previous literature, this study found that an overall decrease in the FCR trajectory for the entire sample over 6 months, with highest levels of FCR at baseline [5] . Savard and Ivers found, in a mixed cancer population, that FCR declined significantly at 2 months and plateaued after that [5] , whereas our study found that FCR appeared to plateau at about 4 months. These differences may be due to differences in study samples and in the measure used to determine FCR. Nevertheless, these findings are consistent with the body of literature that indicates that, particularly for some patients, FCR may persist well after diagnosis and treatment.
After adjusting for relevant covariates, a number of characteristics were found to predict a higher level of FCR at the beginning of the study: not living alone, change in spiritual life since diagnosis, higher state anxiety, greater difficulty coping as a result of disease and treatment, greater distress related to initial diagnosis, and greater distress of illness to family.
These findings corroborate and build on previous work that examined FCR. Across a number of studies, trait and state anxiety were associated with FCR in women with breast cancer [1, 11, 19, 24, 52, 53] . While specific characteristics of anxiety symptoms were not assessed in this sample, the nature of the thoughts that patients with higher levels of FCR experience is similar to that of obsessions (intrusive, unwanted thoughts) [11] . In addition, patients with higher levels of FCR may have a distinct profile from those with lower levels of FCR, whose thoughts are more similar to "worries" (perceived by the individual as rational and ego-syntonic). In addition, intrusive thoughts, hyperarousal, and avoidance, which are all closely related to anxiety, were found to be associated with higher levels of FCR [23] . Additional work on "negative metacognitions" (e.g., the thought that worrying itself is harmful) suggests that these thoughts are associated with higher levels of FCR in young breast cancer survivors [54] ; this relationship was also demonstrated in a sample of early stage breast and prostate survivors [21] . Moreover, clinically significant levels of fear of cancer progression, a closely linked construct with FCR, was comorbid with a diagnosable anxiety disorder in nearly 7 % of a general cancer sample, whereas clinically significant levels of fear of progression alone were seen in 13 % [19] . Future studies need to provide more detailed descriptions of the nature and correlates of anxiety in survivors with FCR, as specific types of anxiety interventions may be warranted for subgroups of patients. Distress related to the cancer diagnosis and greater difficulty coping were associated with higher levels of FCR in prior work [1, 49] . For example, preoperative distress predicted FCR post-surgically, at 3 months, and at 12 months [6] . In terms of coping, self-efficacy (confidence in one's ability to cope with an experience) was inversely correlated with FCR in breast cancer survivors [53] .
Taken together, the characteristics identified in this study that were associated with higher FCR prior to surgery are consistent with the social cognitive theory of coping selfefficacy [55, 56] , in particular the role of self-efficacy in post-traumatic recovery [57] . This model posits that an outcome related to threat appraisal (in this case, FCR) is predicted by coping self-efficacy, which in turn is influenced by both adaptive and maladaptive coping strategies. Coping selfefficacy is the individual's sense that she can cope. While often measured by specific scales [58] , self-efficacy in the present study is best represented by the variable "difficulty coping."
Social influences contribute to coping, but are filtered through the self-efficacy lens. While it may appear paradoxical that not living alone was associated with greater FCR, viewed through the social cognitive lens, it is possible that women with lower coping self-efficacy had more trouble coping with the interpersonal aspects of the diagnosis. Similarly, feeling that one's illness is causing distress to family members may be more distressing to those with lower coping self-efficacy, leading to greater overall distress and FCR. Previous studies found that interpersonal factors (e.g., negative interactions, perceived lower social support) were related to FCR [24, 25] . While findings regarding the relationship between religious/spiritual coping and FCR are inconsistent [1] , our finding that a higher level of spiritual change associated with the cancer diagnosis was associated with greater FCR is consistent with previous work that found a correlation between greater use of religious/spiritual coping and lower FCR. However, one can speculate that the relationship between spiritual change and FCR may be mediated primarily by coping. People who are better able to integrate a new diagnosis into their social, psychological, and spiritual lives (perhaps stressing one of these coping strategies more than the others) may be more confident in their ability to cope with future illness-related events, such as a recurrence. Additional research studies and different approaches to data analysis (e.g., mediation analyses) are needed to clarify the postulated relationships.
Two characteristics, better overall physical health and higher FCR scores at enrollment, significantly predicted steeper declines in FCR scores over the 6 months of the study. The finding that better physical health predicted a steeper decrease in FCR is a novel finding, as few studies that have examined FCR over time have characterized trajectories of FCR or predictors of those trajectories [1] . A previous study found that a higher number of physical symptoms predicted FCR at 1 year following a cancer survivorship rehabilitation program in a sample (n=1281) of diagnostically heterogeneous cancer patients [25] . Taken together, these findings suggest that higher levels of physical symptoms may predict persistence of FCR over time, while better physical health predicts greater reductions in FCR over time. However, given differences in longitudinal analytic methods used as well as variability in measures of physical health, symptoms and FCR, further work is needed to clarify how FCR changes over time in relation to physical symptoms and overall health.
The finding that higher FCR scores at enrollment predicted a steeper decrease in FCR may indicate that these women had more room for FCR to decline, or that, at least in those with higher levels of FCR, some psychological adaptation occurs over time. Further work identifying mechanisms responsible for such adaptation is needed and could point toward interventions specifically targeting those patients with higher FCR scores at diagnosis or treatment initiation.
Several limitations warrant consideration. First, we derived a FCR subscale from a broader QOL instrument. While this subscale has adequate psychometric properties, it was not Fig. 2 Trajectories of fear of cancer recurrence (FCR) scores by (a) living circumstances, (b) changes in spiritual life, (c) state anxiety at enrollment, (d) difficulty coping as a result of treatment/disease, (e) distress due to the initial diagnosis, (f) distress of the illness to family, (g) overall physical health, and (h) FCR scores at enrollment. For the continuous variables, higher/lower differences were calculated based on 1 standard deviation above/below the mean score our sample was relatively homogeneous in terms of demographic characteristics, these findings may not be generalizable to more diverse populations of patients with breast cancer. Third, because we did not assess whether women in this study had current or past diagnoses of anxiety (or other psychiatric) disorders, it is not possible to determine whether the presence of anxiety disorders in some patients may have influenced our results.
Despite these limitations, this work provides a novel perspective on FCR in women with breast cancer. Using HLM, we demonstrated a large amount of inter-individual heterogeneity in women's ratings of FCR both prior to and for 6 months after surgery for breast cancer. Further work is needed to identify those women who may be most at risk for FCR both early and later in the disease, treatment, and survivorship phases. Taken together with findings from numerous other studies that FCR can persist long after completion of treatment [2, [6] [7] [8] [9] [10] , the present findings underscore that FCR remains an important clinical problem that warrants further descriptive as well as intervention research.
In terms of directions for intervention research, early interventions that target high-risk women, for example, by targeting their coping self-efficacy, might help buffer against the persistence of FCR over time. Indeed, Lebel and colleagues' intervention study, which utilized cognitiveexistential group therapy, was theoretically geared toward helping patients address "maladaptive coping strategies," counter "catastrophic thinking," and find "meaning and purpose in life" [59] . Among 44 women with breast or ovarian cancer who had elevated levels of FCR and who completed the 6-week intervention, reductions in FCR, cancer-related distress, and uncertainty, as well as enhanced coping and QOL, were found post-intervention. At 3 months follow-up, these improvements were generally sustained, although improvements in emotional and instrumental coping were not maintained at follow-up [59] . These findings suggest that a brief intervention may help reduce FCR and improve QOL in women with at least moderate levels of FCR, although further work is needed to investigate which aspects of the intervention comprise the active ingredients in reducing FCR, as well as to evaluate how improvements can be sustained over longer time periods. Herschbach and colleagues examined the effects of cognitive-behavioral vs. supportive-experiential group therapy (vs. no-treatment control) in a mixed cancer sample (n=174) [60] . The authors reported improvements in fear of progression and secondary outcome measures (depression, anxiety), although general life satisfaction did not improve. Mindfulness-based stress reduction also demonstrated efficacy in reducing FCR among breast cancer survivors [61, 62] . Another promising intervention strategy for FCR, currently the subject of an ongoing trial in breast and colon cancer survivors [63] , utilizes principles and techniques of Acceptance and Commitment Therapy (ACT) such as metacognitive, detached mindfulness, and values-driven approaches [64] . Given the pervasiveness and impact of FCR, as well as the growing population of cancer survivors, these and other lines of research into FCR-and its related distress and impact on QOL-are needed to evaluate and compare potential therapeutic modalities as well as to identify key mechanisms of action in effective interventions.
